Intravenous Tirofiban After Bridging Therapy for Acute Stroke With Atherosclerotic Large Artery Occlusion
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 564 participants.
Also called NCT07335107
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 564 participants
- Sponsor
- Registry
-
NCT07335107
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07335107. Randomized; no masking; primary purpose treatment. Start 2026-01-12 (anticipated); primary completion 2027-01-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intravenous Tirofiban After Bridging Therapy for Acute Stroke With Atherosclerotic Large Artery Occlusion
- Acronym
- RESCUE-AS
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Intravenous Tirofiban
- Intervention (Drug)
- Standard Medical Therapy
- Lead sponsor
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct07335107- Content hash
c393ebfa543cc608535854af93180f21323a09cedba709b7614c6ed6b6da6e02